Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$53.16M-182%$43.7M+470%$21.57M+74.9%-$9.39M+44.9%-$18.84M-797%
$4.17M+21.2%$4.07M+12.5%$4.03M+12.9%$3.73M+10.9%$3.44M+12.1%
$3.64M+8.0%$4.32M+49.6%$3.07M+13.0%$2.54M-1.0%$3.37M+39.9%
$21.13M+206%-$32.87M-794%-$19.94M-96.2%
$3.15M-13.2%$4.65M+38.4%$2.24M-13.0%$3.64M+93.5%$3.63M+63.2%
-$3.15M+13.2%-$4.65M-38.4%-$2.24M+13.0%-$3.64M-93.5%-$3.63M-63.2%
-$20.21M-883%-$4.81M-114%-$10.21M-509%-$288K+83.3%-$2.06M+21.2%
-$2.23M+91.3%-$9.36M-$36.8M-$25.62M-70.9%
$17.98M+176%-$36.51M-$23.56M-90.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Organogenesis Holdings Inc. generate?
Organogenesis Holdings Inc. (ORGO) generated -$20.7M in operating cash flow over the trailing twelve months.
What is Organogenesis Holdings Inc.'s free cash flow?
After $13.7M of capital expenditures, Organogenesis Holdings Inc.'s free cash flow was -$34.5M over the trailing twelve months, down 67.6% year over year.
Where does Organogenesis Holdings Inc.'s cash flow data come from?
Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.